Allarity Therapeutics, Inc.
ALLR
$1.28
$0.032.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.33M | -11.25M | -11.23M | -15.31M | -24.10M |
| Total Depreciation and Amortization | -28.00K | -50.00K | -13.00K | -20.00K | 29.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.14M | 2.18M | 2.10M | 581.00K | 10.06M |
| Change in Net Operating Assets | -4.48M | -7.50M | -5.68M | -33.00K | -2.81M |
| Cash from Operations | -13.71M | -16.63M | -14.82M | -14.78M | -16.82M |
| Capital Expenditure | -72.00K | -72.00K | -8.00K | -298.00K | -298.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -72.00K | -72.00K | -8.00K | -298.00K | -298.00K |
| Total Debt Issued | 20.00M | 20.00M | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 2.70M | 2.70M | 13.84M | 17.83M | 20.81M |
| Repurchase of Common Stock | -887.00K | -3.45M | -3.19M | -2.71M | -2.57M |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 2.94M |
| Repurchase of Preferred Stock | -- | -- | -- | 0.00 | -3.50M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.81M | 19.25M | 10.65M | 15.12M | 17.68M |
| Foreign Exchange rate Adjustments | 1.15M | -439.00K | -667.00K | -1.61M | -2.00M |
| Miscellaneous Cash Flow Adjustments | 1.00K | 1.00K | 1.00K | -- | -- |
| Net Change in Cash | 9.18M | 2.11M | -4.85M | -1.57M | -1.43M |